PASQUINI, MARIA CRISTINA
PASQUINI, MARIA CRISTINA
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
FarmaREL : an Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients
2017 N.S. Fracchiolla, S. Artuso, A. Cortelezzi, A.M. Pelizzari, P. Tozzi, M. Bonfichi, F. Bocchio, L. Gargantini, E. De Rosa, G.D. Vighi, L. Prestini, S. Sammassimo, N. Frungillo, M.C. Pasquini, A. Ragazzi, D. Boghi, A. Pastore, E. Lanzi, G. Gritti, G. Quaresmini, S. Voltolini, R. Gaiardoni, C. Corti, M.C. Vilardo, M.L. La Targia, G. Berini, M. Magagnoli, C. Bacci, D. Consonni, A.L. Rivolta, G. Muti
Analisi del profilo di espressione dei geni dell'apoptosi nelle LLC mediante microfluidic cards
2009 M.C. Pasquini
Low-dose subcutaneous alemtuzumab in refractory chronic lymphocytic leukaemia (CLL) : results of a prospective, single-arm multicentre study
2009 A. Cortelezzi, M.C. Pasquini, A. Gardellini, U. Gianelli, A. Bossi, G. Reda, B. Sarina, P. Musto, W. Barcellini, A. Neri, G. Lambertenghi Deliliers
Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status
2008 A. Cortelezzi, G. Gritti, N. Del Papa, M.C. Pasquini, R. Calori, U. Gianelli, M. Cortiana, G. Parati, F. Onida, F. Sozzi, C. Vener, P. Bianchi, G. Lambertenghi Deliliers
Biological and molecular differences between the dysplastic and the proliferative variants of chronic myelomonocytic leukemia
2007 F. Onida, C. Ricci, F. Servida, E. Fermo, C. Miranda, A. Vismara, M.C. Pasquini, A. Faricciotti, A. Cortelezzi, G. Lambertenghi Deliliers
Gene expression signature of the apoptotic patway in indolent CLL by low-density array technology
2007 A. Cortelezzi, U. Gianelli, V. Vaira, M.C. Pasquini, E. Fasoli, A. Neri, L. Nobili, L. Lionetti, M. Cortiana, D. Vinventi, S. Bosari, G. Coggi, G. Lambertenghi Deliliers
Apoptosis taqman low-density array : analysis of programmed cell death patway in CLL
2007 A. Cortelezzi, U. Gianelli, V. Vaira, M.C. Pasquini, E. Fasoli, A. Neri, L. Nobili, M. Lionetti, M. Cortiana, D. Vincenti, S. Bosari, G. Coggi, G. Lambertenghi Deliliers
Low-dose subcutaneous campath (CAM) is highly effective and safe in advanced and chemotherapy-refractory B-CLL : results of a prospectic and multicenter phase II study
2007 A. Cortelezzi, M.C. Pasquini, W. Barcellini, P. Musto, U. Gianelli, G. Reda, G. Lambertenghi Deliliers
Chronic idiopathic myelofibrosis complicated by pulmonary arterial hypertension is distinctively characterized by endothelial progenitor cell insufficiency and increased angiogenesis
2007 A. Cortelezzi, G. Gritti, N. Del Papa, M.C. Pasquini, M. Cortiana, I. Silvestris, R. Calori, U. Gianelli, C. Vener, F. Sozzi, G. Parati, G. Lambertenghi Deliliers
Role of dasatinib in PH '-positive acute lymphoblastic leukemia (ALL) after imatinib-based therapy failure : a case report
2007 A. Cortelezzi, M.C. Pasquini, F. Radaelli, G. Reda, F. Ripamonti, A. Gardellini, D. Intini, O. Spinelli, G. Lambertenghi Deliliers
Correlation between microvessel density (MVD) and vascular endothelial growth factor (VEGF) expression in myelodysplastic syndromes(MDS)
2007 N.S. Fracchiolla, U. Gianelli, C. Vener, E. De Cavilli, M.C. Pasquini, M.A. Colombi, S. Bosari, A. Cortelezzi, G. Lambertenghi Deliliers
Role of mature and progenitor endothelial cells in pre-eclampsia
2007 V. Cozzi, G. Alvino, S. Calabrese, N. Fracchiolla, A. Martinelli, M.C. Pasquini, M. Cortiana, I. Silvestris, A. Cortelezzi, I. Cetin
Low-dose ALEMTUZUMAB monotherapy in advanced chronic lymphocytic leukemia
2006 A. Cortelezzi, M.C. Pasquini, G. Reda, F. Ripamonti, B. Sarina, W. Barcellini, G. Lambertenghi Deliliers
Fludarabine-Ifosfamide-Rituximab (FIR): a therapeutic option for chronic lymphocytic leukemia patients resistant to Chlorambucil
2006 A. Cortelezzi, M. Pasquini, G. Reda, F. Ripamonti, D. G Lambertenghi
Low dose campath 1-H is highly effective and safe in advanced chronic CLL
2006 A. Cortelezzi, M.C. Pasquini, U. Gianelli, B. Sarina, C. Vener, G. Reda, F. Ripamonti, L. Nobili, G. Lambertenghi Deliliers
Endothelial progenitor and circulating endothelial cells in patients with systemic sclerosis (SSC): short-term Simvastatin treatment improves endothelial function
2006 A. Cortelezzi, M. Pasquini, T. Lucchi, W. Maglione, M. Cortiana, I. Silvestris, G. LAMBERTENGHI DELILIERS, N. Del Papa
Pulmonary arterial hypertension in idiopathic myelofibrosis is associated with an altered angiogenic status
2006 A. Cortelezzi, N. Del Papa, R. Calori, M.C. Pasquini, M. Cortiana, I. Silvestris, G. Gritti, F.B. Sozzi, P. Bianchi, G. Lambertenghi Deliliers
Pathogenetic role of mature and progenitor endothelial cells in pre-eclampsia
2006 A. Cortelezzi, N.S. Fracchiolla, M. Cortiana, M.C. Pasquini, I. Silvestris, I. Cetin, V. Cozzi, G. Pardi, G. Lambertenghi Deliliers
Involvement of RAS, JAK2 and GM-CSF in the pathogenesis of proliferative variant of chronic myelomonocytic leukaemia
2006 F. Onida, F. Servida, C. Ricci, E. Fermo, M.C. Pasquini, A. Vismara, A. Cortelezzi, S. Soligo, G. Lambertenghi Deliliers
ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia
2006 C. Vener, U. Gianelli, A. Cortelezzi, N.S. Fracchiolla, F. Somalvico, F. Savi, M.C. Pasquini, S. Bosari, G. Lambertenghi Deliliers